Migraine

The Pharmacy Times® Migraine Resource Center is a comprehensive resource for clinical news and expert insights on treatments for migraine headaches, which can cause severe throbbing pain or a pulsing sensation.

Daily Medication Pearl: Galcanezumab-gnlm (Emgality)

March 16, 2022

Article

Galcanezumab-gnlm (Emgality) is indicated in adults for the preventive treatment of migraine and treatment of episodic cluster headache.

Study Results Show Possible Link Between Hormone Levels Before Birth and Migraine Risk

March 15, 2022

Article

Analysis assessing data from the world’s largest twin registry also finds evidence that genetic factors for strong headaches may differ between men and women.

Migraines Can Affect Ability to Work, Study Results Show

March 10, 2022

Article

Headache disorders most affect the ability to do physical labor, decision-making skills, and memory, investigators from the University of Copenhagen say.

Study: Women With Migraines Show Higher Risk of Pregnancy Complications

March 09, 2022

Article

Although the risks are still, individuals with a history of migraines should be aware of and consult with their physicians, investigators say.

The Consequences of Discontinuing CGRP Inhibitors in Migraine Patients

March 09, 2022

Article

Pharmacists must understand the value of monitoring changes in quality of life and headache frequency to help facilitate the decision to continue, discontinue, or restart migraine prophylaxis.

The Role of Erenumab (Aimovig) in Treating Episodic, Chronic Migraines

March 02, 2022

Article

Erenumab (Aimovig) was the first anti-CGRP agent approved by the FDA for migraine prophylaxis.

Electrical Neuromodulation Device Improves Symptoms of Acute Migraine

February 23, 2022

Article

Nerivio is the first FDA-cleared smartphone-controlled prescribed wearable device for the acute treatment of migraine.

Qulipta From AbbVie

January 28, 2022

Article

The FDA has approved atogepant oral tablets (Qulipta; AbbVie) for the preventive treatment of episodic migraines in adults.

Overview of Nurtec ODT for Prevention of Episodic Migraine

January 04, 2022

Article

Nurtec is the first oral calcitonin gene-related peptide antagonist approved for both acute and preventative treatment of migraine.

Plant-Based Diet Might Ease Symptoms of Chronic Migraines, Case Study Suggests

November 25, 2021

Article

Physicians advised the individual to adopt the Low Inflammatory Foods Everyday (LIFE) diet, which is a nutrient dense, whole food, plant-based diet.